BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 9118522)

  • 1. Angiotensin-converting enzyme inhibition prevents arterial nuclear factor-kappa B activation, monocyte chemoattractant protein-1 expression, and macrophage infiltration in a rabbit model of early accelerated atherosclerosis.
    Hernández-Presa M; Bustos C; Ortego M; Tuñon J; Renedo G; Ruiz-Ortega M; Egido J
    Circulation; 1997 Mar; 95(6):1532-41. PubMed ID: 9118522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ACE inhibitor quinapril reduces the arterial expression of NF-kappaB-dependent proinflammatory factors but not of collagen I in a rabbit model of atherosclerosis.
    Hernández-Presa MA; Bustos C; Ortego M; Tuñón J; Ortega L; Egido J
    Am J Pathol; 1998 Dec; 153(6):1825-37. PubMed ID: 9846973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiotensin II participates in mononuclear cell recruitment in experimental immune complex nephritis through nuclear factor-kappa B activation and monocyte chemoattractant protein-1 synthesis.
    Ruiz-Ortega M; Bustos C; Hernández-Presa MA; Lorenzo O; Plaza JJ; Egido J
    J Immunol; 1998 Jul; 161(1):430-9. PubMed ID: 9647253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiotensin II and tumor necrosis factor-alpha synergistically promote monocyte chemoattractant protein-1 expression: roles of NF-kappaB, p38, and reactive oxygen species.
    Takahashi M; Suzuki E; Takeda R; Oba S; Nishimatsu H; Kimura K; Nagano T; Nagai R; Hirata Y
    Am J Physiol Heart Circ Physiol; 2008 Jun; 294(6):H2879-88. PubMed ID: 18441197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Local overexpression of monocyte chemoattractant protein-1 at vessel wall induces infiltration of macrophages and formation of atherosclerotic lesion: synergism with hypercholesterolemia.
    Namiki M; Kawashima S; Yamashita T; Ozaki M; Hirase T; Ishida T; Inoue N; Hirata K; Matsukawa A; Morishita R; Kaneda Y; Yokoyama M
    Arterioscler Thromb Vasc Biol; 2002 Jan; 22(1):115-20. PubMed ID: 11788470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensin III increases MCP-1 and activates NF-kappaB and AP-1 in cultured mesangial and mononuclear cells.
    Ruiz-Ortega M; Lorenzo O; Egido J
    Kidney Int; 2000 Jun; 57(6):2285-98. PubMed ID: 10844599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ezetimibe reduces plaque inflammation in a rabbit model of atherosclerosis and inhibits monocyte migration in addition to its lipid-lowering effect.
    Gómez-Garre D; Muñoz-Pacheco P; González-Rubio ML; Aragoncillo P; Granados R; Fernández-Cruz A
    Br J Pharmacol; 2009 Apr; 156(8):1218-27. PubMed ID: 19222481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of the NF-kappa B and I kappa B system in smooth muscle cells after rat arterial injury. Induction of vascular cell adhesion molecule-1 and monocyte chemoattractant protein-1.
    Landry DB; Couper LL; Bryant SR; Lindner V
    Am J Pathol; 1997 Oct; 151(4):1085-95. PubMed ID: 9327742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual regulation of tumor necrosis factor-alpha-induced CCL2/monocyte chemoattractant protein-1 expression in vascular smooth muscle cells by nuclear factor-kappaB and activator protein-1: modulation by type III phosphodiesterase inhibition.
    Chen YM; Chiang WC; Lin SL; Wu KD; Tsai TJ; Hsieh BS
    J Pharmacol Exp Ther; 2004 Jun; 309(3):978-86. PubMed ID: 14978197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of inhibitory protein-kappaB and monocyte chemoattractant protein-1 by angiotensin II type 2 receptor-activated Src homology protein tyrosine phosphatase-1 in fetal vascular smooth muscle cells.
    Wu L; Iwai M; Li Z; Shiuchi T; Min LJ; Cui TX; Li JM; Okumura M; Nahmias C; Horiuchi M
    Mol Endocrinol; 2004 Mar; 18(3):666-78. PubMed ID: 14684844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calcineurin promotes the expression of monocyte chemoattractant protein-1 in vascular myocytes and mediates vascular inflammation.
    Satonaka H; Suzuki E; Nishimatsu H; Oba S; Takeda R; Goto A; Omata M; Fujita T; Nagai R; Hirata Y
    Circ Res; 2004 Mar; 94(5):693-700. PubMed ID: 14739159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin II as a pro-inflammatory mediator.
    Phillips MI; Kagiyama S
    Curr Opin Investig Drugs; 2002 Apr; 3(4):569-77. PubMed ID: 12090726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of monocyte chemoattractant protein 1 in macrophage-rich areas of human and rabbit atherosclerotic lesions.
    Ylä-Herttuala S; Lipton BA; Rosenfeld ME; Särkioja T; Yoshimura T; Leonard EJ; Witztum JL; Steinberg D
    Proc Natl Acad Sci U S A; 1991 Jun; 88(12):5252-6. PubMed ID: 2052604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ACE inhibition lowers angiotensin II-induced chemokine expression by reduction of NF-kappaB activity and AT1 receptor expression.
    Schmeisser A; Soehnlein O; Illmer T; Lorenz HM; Eskafi S; Roerick O; Gabler C; Strasser R; Daniel WG; Garlichs CD
    Biochem Biophys Res Commun; 2004 Dec; 325(2):532-40. PubMed ID: 15530425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of P2Y12 receptor in vascular smooth muscle inflammatory changes via MCP-1 upregulation and monocyte adhesion.
    Satonaka H; Nagata D; Takahashi M; Kiyosue A; Myojo M; Fujita D; Ishimitsu T; Nagano T; Nagai R; Hirata Y
    Am J Physiol Heart Circ Physiol; 2015 Apr; 308(8):H853-61. PubMed ID: 25681429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiotensin II receptor blocker valsartan suppresses reactive oxygen species generation in leukocytes, nuclear factor-kappa B, in mononuclear cells of normal subjects: evidence of an antiinflammatory action.
    Dandona P; Kumar V; Aljada A; Ghanim H; Syed T; Hofmayer D; Mohanty P; Tripathy D; Garg R
    J Clin Endocrinol Metab; 2003 Sep; 88(9):4496-501. PubMed ID: 12970329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytokine induction of monocyte chemoattractant protein-1 gene expression in human endothelial cells depends on the cooperative action of NF-kappa B and AP-1.
    Martin T; Cardarelli PM; Parry GC; Felts KA; Cobb RR
    Eur J Immunol; 1997 May; 27(5):1091-7. PubMed ID: 9174597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of angiotensin converting enzyme in the neointima after vascular injury. Possible role in restenosis.
    Rakugi H; Kim DK; Krieger JE; Wang DS; Dzau VJ; Pratt RE
    J Clin Invest; 1994 Jan; 93(1):339-46. PubMed ID: 8282805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced MCP-1 expression during ischemia/reperfusion injury is mediated by oxidative stress and NF-kappaB.
    Sung FL; Zhu TY; Au-Yeung KK; Siow YL; O K
    Kidney Int; 2002 Oct; 62(4):1160-70. PubMed ID: 12234286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HMG-CoA reductase inhibition by atorvastatin reduces neointimal inflammation in a rabbit model of atherosclerosis.
    Bustos C; Hernández-Presa MA; Ortego M; Tuñón J; Ortega L; Pérez F; Díaz C; Hernández G; Egido J
    J Am Coll Cardiol; 1998 Dec; 32(7):2057-64. PubMed ID: 9857893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.